Larvol Delta - CAP100-for-Subjects-With-RelapsedRefractory-Chronic-Lymphocytic-Leukemia

CAP-100 - Catapult Therap

http://clinicaltrials.gov/ct2/show/NCT04704323

Jan 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev